Eric Semler Acquires 26,868 Shares of Semler Scientific, Inc. (NASDAQ:SMLR) Stock

Semler Scientific, Inc. (NASDAQ:SMLR) Director Eric Semler bought 26,868 shares of the business’s stock in a transaction on Wednesday, September 13th. The stock was purchased at an average price of $28.11 per share, with a total value of $755,259.48. Following the completion of the transaction, the director now directly owns 77,771 shares of the company’s stock, valued at $2,186,142.81. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink.

Eric Semler also recently made the following trade(s):

• On Monday, September 11th, Eric Semler purchased 25,000 shares of Semler Scientific stock. The shares were purchased at an average price of $26.98 per share, for a total transaction of $674,500.00.

Semler Scientific Stock Up 1.6 %

Shares of Semler Scientific stock opened at $28.18 on Friday. The business has a fifty day simple moving average of $25.90 and a 200-day simple moving average of $25.54. The firm has a market cap of $193.68 million, a price-to-earnings ratio of 12.52 and a beta of 0.67. Semler Scientific, Inc. has a fifty-two week low of $19.12 and a fifty-two week high of $44.36.

Hedge Funds Weigh In On Semler Scientific

Several large investors have recently made changes to their positions in the business. Cerity Partners LLC boosted its holdings in Semler Scientific by 15.1% during the fourth quarter. Cerity Partners LLC now owns 701,183 shares of the company’s stock worth $23,139,000 after buying an additional 92,040 shares in the last quarter. AltraVue Capital LLC lifted its position in shares of Semler Scientific by 33.8% during the 4th quarter. AltraVue Capital LLC now owns 437,277 shares of the company’s stock valued at $14,430,000 after acquiring an additional 110,580 shares during the last quarter. Nantahala Capital Management LLC boosted its stake in shares of Semler Scientific by 27.9% during the 1st quarter. Nantahala Capital Management LLC now owns 356,875 shares of the company’s stock worth $17,687,000 after acquiring an additional 77,790 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Semler Scientific by 267.5% in the 2nd quarter. BlackRock Inc. now owns 287,712 shares of the company’s stock worth $7,550,000 after acquiring an additional 209,428 shares during the last quarter. Finally, Goldman Sachs Group Inc. raised its position in shares of Semler Scientific by 49.7% during the first quarter. Goldman Sachs Group Inc. now owns 227,529 shares of the company’s stock worth $11,276,000 after purchasing an additional 75,574 shares during the period. Institutional investors own 93.60% of the company’s stock.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.